Speaker illustration

Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

Member of:

European Society of Cardiology

Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement

Event: ESC Congress 2025

Topic: Aortic Valve Intervention

Session: Thromboembolic events and stroke in TAVI

Thumbnail

Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation

Event: ESC Congress 2025

Topic: Aortic Valve Intervention

Session: Coexistence of coronary disease and aortic stenosis: challenges in percutaneous vs. surgical approach

Thumbnail

High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation

Event: ESC Congress 2023

Topic: Aortic Valve Intervention

Session: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Thumbnail

Increased clot strength following transcatheter aortic valve replacement

Event: ESC Congress 2023

Topic: Aortic Valve Intervention

Session: Can we prevent strokes during TAVI?

Thumbnail